Toshihiko Masui

6.0k citations
137 papers · 4.3k indexed · 1 hit paper · h-index 31

Toshihiko Masui

127 papers receiving 4.2k citations

Hit Papers

Continuous cell supply from a Sox9-expressing progenitor ...6412010202620152020200400600

Peers

Toshihiko Masui
Comparison fields: 5 of 118
  • Oncology 1.7k
  • Hepatology 324
  • Molecular Medicine 185
  • Surgery 1.6k
  • Cancer Research 500
Replace Wen Yue with:
Wen Yue China
Hiroaki Okuyama Japan
Pascal Colosetti France
Swarnali Acharyya United States
Masayuki Koizumi Japan
Josep Baulida Spain
In‐Sun Chu South Korea
Ayyakkannu Ayyanan Switzerland
Koh‐ichi Nakashiro Japan
Baoan Ji United States
Toshihiko Masui relative to Wen Yue China Wen Yue's profile →
Citations per field
00.5×8.8×
Wen Yue · 1×
Citations per year

Countries citing papers authored by Toshihiko Masui

Since Specialization
Citations

This map shows the geographic impact of Toshihiko Masui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihiko Masui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihiko Masui more than expected).

Fields of papers citing papers by Toshihiko Masui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshihiko Masui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihiko Masui. The network helps show where Toshihiko Masui may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Toshihiko Masui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Toshihiko Masui Line = papers co-authored together Toshihiko Masui links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20244
4 20231
5 20221
6 202216
7 20222
8 20205
9 20176
10 20174
11 201620
12 201523
13 20154
14 20112
15 201129
16 201057
17 2007127
18 2005170
19 200514
20 2004117

About Toshihiko Masui

Toshihiko Masui is a scholar working on Oncology, Surgery and Hepatology, having authored 137 papers that have together received 4.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (52 papers), Neuroendocrine Tumor Research Advances (36 papers), Pancreatitis Pathology and Treatment (25 papers), Lung Cancer Research Studies (18 papers), Pancreatic function and diabetes (16 papers), Neuroblastoma Research and Treatments (13 papers), Gallbladder and Bile Duct Disorders (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers). The work is most often cited by research in Oncology (1.7k citations), Hepatology (324 citations) and Molecular Medicine (185 citations). Toshihiko Masui has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Ryuichiro Doi, Shinji Üemoto, Masayuki Koizumi, Yoshiya Kawaguchi, Masayuki Imamura, Raymond J. MacDonald, Kyoichi Takaori, Koji Fujimoto, Eiji Toyoda and Kazuhiro Kami. Their work appears in journals such as Nature Genetics, Journal of Clinical Oncology and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026